NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

橫向流量測定的全球市場

Lateral Flow Assays

出版商 Global Industry Analysts, Inc. 商品編碼 908008
出版日期 內容資訊 英文 340 Pages
商品交期: 最快1-2個工作天內
價格
橫向流量測定的全球市場 Lateral Flow Assays
出版日期: 2021年05月01日內容資訊: 英文 340 Pages
簡介

本報告提供全球橫向流量測定的市場相關分析,彙整整體市場規模的實際成果值·預測值,及主要推動及阻礙市場要素,各產品·各產業·各用途及各企業的市場佔有率趨勢 (過去9年·今後8年份),今後的市場成長的方向性,各地區·主要國家的市場詳細趨勢等調查,主要企業的簡介等資訊,為您概述為以下內容。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值·預測值)
    • 各市場區隔的市場佔有率結構 (最新值·預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模·佔有率趨勢預測:各地區/各國
    • 各產品 (套件·試劑,側流領導者)
    • 各最終用途產業 (醫院·診療所,診斷檢驗室,家庭治療,製藥·生物科技企業等)
    • 各用途 (臨床檢驗,食品·環境安全,獸醫診斷,藥物研發·品管)
      • 市場規模:各地區/各國 (過去9年·今後8年份)
      • 市場佔有率:各地區/各國 (總計17年份)

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 橫向流量測定的市場規模 (實際成果值·預測值)
    • 各產品的市場規模 (實際成果值·預測值)
    • 各產業市場規模 (實際成果值·預測值)
    • 各用途的市場規模 (實際成果值·預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲 (法國,德國,義大利,英國,西班牙,俄羅斯等)
  • 亞太地區 (澳洲,印度,韓國等)
  • 南美 (阿根廷,巴西,墨西哥等)
  • 中東 (伊朗,以色列,沙烏地阿拉伯,UAE等)
  • 非洲

第4章 企業

  • ABBOTT LABORATORIES
  • ALERE
  • BIO-RAD LABORATORIES
  • DANAHER CORPORATION
  • F. HOFFMANN-LA ROCHE AG
  • HOLOGIC
  • JOHNSON & JOHNSON
  • PERKINELMER
  • QIAGEN NV
  • QUIDEL CORPORATION
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC
  • BIOMeRIEUX SA

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP12971

Abstract:

Global Lateral Flow Assays Market to Reach US$11.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Lateral Flow Assays estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$11.6 Billion by 2027, growing at a CAGR of 5.9% over the period 2020-2027.Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lateral Flow Readers segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 17.9% share of the global Lateral Flow Assays market.

The U.S. Accounts for Over 38.6% of Global Market Size in 2020, While China is Forecast to Grow at a 8.8% CAGR for the Period of 2020-2027

The Lateral Flow Assays market in the U.S. is estimated at US$3 Billion in the year 2020. The country currently accounts for a 38.64% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$917 Million in the year 2027 trailing a CAGR of 8.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$917 Million by the year 2027.

Select Competitors (Total 55 Featured) -

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Johnson & Johnson
  • PerkinElmer, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
    • Impact of COVID-19 on Lateral Flow Assays Market
    • Performance Analysis of COVID-19 Tests
    • EXHIBIT 2: COVID-19 Cases Worldwide by Country: As on May 17, 2021
    • Lateral Flow Assay-based Tests Soar into Spotlight during COVID-19 Pandemic
    • LFAS Arms Nations to Battle the Coronavirus
  • GLOBAL MARKET OVERVIEW
    • A Prelude to Lateral Flow Technology
    • Lateral Flow Assays: An Introduction
    • Lateral Flow Assays: A Mighty, Paper-based Diagnostics Approach
    • Lateral Flow Assays Market Poised to Experience Uninterrupted Flow Ahead
    • Clinical Testing Remains Primary Application Segment of Lateral Flow Assays Market
    • Rising Incidence of Infectious Conditions Ignite Demand
    • LFA Overcomes Testing Barriers
    • The US Retains Leadership Tag in Global Lateral Flow Assays Market
    • Fast Paced Growth Projected in Developing Regions
    • Market Outlook
    • Competitive Scenario
  • RECENT MARKET ACTIVITY
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Infectious Diseases to Drive LFA Market
    • EXHIBIT 3: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • EXHIBIT 4: Global Malaria Case Incidence Rate (per 1,000 population) for the Years 2015, 2016, 2017 & 2018
    • EXHIBIT 5: Global TB Cases (In Millions) Reported to Have Been Treated for the Years 2015-2019
    • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
    • EXHIBIT 6: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • EXHIBIT 7: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Viral Hepatitis Testing Presents Opportunities for Lateral Flow Assays Market
    • EXHIBIT 8: Hepatitis B prevalence Worldwide by Region
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • EXHIBIT 10: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Ageing Demographics to Drive Demand
    • EXHIBIT 11: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 12: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Self-Diagnosis Emerges as a Notable Trend
    • New Approvals of Self-Test Devices to Give a Boost to the Market
    • Lateral Flow Assays Hold Rosy Outlook with Emerging Applications Areas
    • LFAs Gains Foothold in Multiplexing
    • Multiplexed Point-Of-Care Testing
    • Remote Healthcare Benefits Lateral Flow Assays Market
    • Lateral Flow Assays to Become Landmark Approach in Precision Diagnostics
    • Lateral Flow Assays & Precision Diagnostics
    • Digitalization of Lateral Flows to Support Healthcare
    • Digitalized Lateral Flow Assays: An Exciting Platform to Change Data-Driven Healthcare Domain
    • Lateral Flow Assays Emerge as Integral Components of Food Safety & Environmental Testing
    • Novel Lateral Flow Assay Marks Shift from Reactive to Proactive Food Safety Testing Approach
    • Technological Advancements Remain Crucial to Future Growth
    • Researchers Develop Novel Technique to Significantly Increase Accuracy of Lateral Flow Tests
    • Smartphone-based Fully-Quantitative Lateral Flow Assay Analyzer for Reliable & Quick Diagnosis
    • Innovative Lateral Flow Immunoassays Find Increasing Role in Detection of Dengue & Zika Virus
    • Abingdon Health Introduced ADxLR5® Developer for Assay Development
    • Rapid Tests Connectivity with Wireless Data Platforms
    • Miniaturization of Analytical Instruments Presents Lucrative Opportunities for Handheld Lateral Flow Assay Readers
    • Low Accuracy Remains a Major Restraint
    • Limited Reimbursement & Raw Material Supply Issues as Key Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Lateral Flow Readers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Lateral Flow Readers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Lateral Flow Readers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Veterinary Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Veterinary Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Veterinary Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 67: Europe Current & Future Analysis for Lateral Flow Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Lateral Flow Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 115: Spain Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 121: Spain Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 124: Russia Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 130: Russia Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 133: Rest of Europe Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 142: Asia-Pacific Current & Future Analysis for Lateral Flow Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Lateral Flow Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 154: Australia Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 160: Australia Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 163: India Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 169: India Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 172: South Korea Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 178: South Korea Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 190: Latin America Current & Future Analysis for Lateral Flow Assays by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Lateral Flow Assays by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 202: Brazil Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Brazil Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Brazil 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 205: Brazil Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Brazil Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Brazil 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 208: Brazil Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Brazil 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 211: Mexico Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Mexico Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Mexico 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 214: Mexico Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Mexico Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Mexico 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 217: Mexico Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Mexico 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 220: Rest of Latin America Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Rest of Latin America Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Rest of Latin America 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 223: Rest of Latin America Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Rest of Latin America Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Rest of Latin America 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 226: Rest of Latin America Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 229: Middle East Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Middle East Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Middle East 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 232: Middle East Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Middle East Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Middle East 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 235: Middle East Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Middle East 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 238: Africa Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Africa Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Africa 15-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2012, 2020 & 2027
    • TABLE 241: Africa Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Africa Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Africa 15-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 244: Africa Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Africa Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Africa 15-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 55